Farmasierra
Almudena Cantero Vaquero is an accomplished analytical laboratory analyst with over two decades of experience in the pharmaceutical and environmental sectors. Currently serving as an Analista de laboratorio de desarrollo analítico at Farmasierra since March 2003, Almudena focuses on stability analysis for new product development and validation of analytical methods. Prior experience includes a role at Instituto de Salud Carlos III, where sample preparation for veterinary residue control methods took place, and an analytical position at DENGA S.A., performing analyses of various environmental samples. Almudena also possesses foundational laboratory skills from an earlier role at CLH, specializing in hydrocarbon testing. Educational qualifications include advanced training in Chemical Process Industries and Analysis and Control from I.E.S Palomeras-Vallecas.
This person is not in any offices
Farmasierra
Grupo Farmasierra is a pharmaceutical group that specialises in research and development and the manufacture, distribution and commercialisation of medicinal products, food supplements and cosmetics. The Group consists of 205 employees distributed in its four business areas; it has a revenue of 40 million euros and is in full growth. It currently has offices in Spain (Madrid, Barcelona). The Group's activity ranges from the preliminary research needed to develop and optimise the production of a medicinal product, food supplements and cosmetics to the integral management of manufacturing its distribution and promotion. Grupo Farmasierra carries out contract manufacturing and technology development services at the international level for the entire European Union, and for over 20 additional countries. Moreover, it provides third parties with distribution services at the national level and commercialises its products in Spain and Portugal. The on-going incorporation of new knowledge is key to the consolidation of all its areas and its expansion over time. Therefore, Grupo Farmasierra attends major international forums on formulation and pharmaceutical innovation and is in contact with the main sources of specialised information, including several universities and research institutes.